Vontobel Holding Ltd. Grows Stake in Kenvue Inc. (NYSE:KVUE)

Vontobel Holding Ltd. boosted its holdings in shares of Kenvue Inc. (NYSE:KVUE - Free Report) by 46.0% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 45,744 shares of the company's stock after purchasing an additional 14,409 shares during the period. Vontobel Holding Ltd.'s holdings in Kenvue were worth $1,097,000 at the end of the most recent reporting period.

Other hedge funds also recently bought and sold shares of the company. SRS Capital Advisors Inc. boosted its position in Kenvue by 67.4% during the 4th quarter. SRS Capital Advisors Inc. now owns 1,418 shares of the company's stock valued at $30,000 after acquiring an additional 571 shares in the last quarter. Clarity Asset Management Inc. purchased a new stake in shares of Kenvue in the 4th quarter worth approximately $45,000. SBI Securities Co. Ltd. purchased a new stake in shares of Kenvue in the 4th quarter worth approximately $46,000. Continuum Advisory LLC boosted its stake in Kenvue by 2,071.1% in the 1st quarter. Continuum Advisory LLC now owns 1,954 shares of the company's stock worth $47,000 after purchasing an additional 1,864 shares in the last quarter. Finally, Golden State Wealth Management LLC grew its position in Kenvue by 292.0% during the 1st quarter. Golden State Wealth Management LLC now owns 3,081 shares of the company's stock valued at $74,000 after purchasing an additional 2,295 shares during the last quarter. Hedge funds and other institutional investors own 97.64% of the company's stock.

Analyst Upgrades and Downgrades

Several equities analysts recently issued reports on the company. Redburn Atlantic assumed coverage on Kenvue in a research report on Thursday, April 10th. They issued a "neutral" rating and a $23.50 price objective on the stock. Barclays upped their price objective on Kenvue from $22.00 to $23.00 and gave the stock an "equal weight" rating in a research note on Monday, May 12th. Evercore ISI assumed coverage on Kenvue in a research note on Monday, March 24th. They issued an "in-line" rating and a $25.00 price objective for the company. UBS Group upped their price objective on Kenvue from $24.00 to $25.00 and gave the stock a "neutral" rating in a research note on Friday, May 9th. Finally, Citigroup restated a "neutral" rating on shares of Kenvue in a research note on Friday, June 13th. Seven analysts have rated the stock with a hold rating and five have given a buy rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of "Hold" and an average price target of $25.33.

Kenvue Price Performance

KVUE stock traded up $0.12 during trading on Friday, reaching $21.02. The company's stock had a trading volume of 6,093,067 shares, compared to its average volume of 16,141,426. Kenvue Inc. has a 1 year low of $17.67 and a 1 year high of $25.17. The company has a quick ratio of 0.60, a current ratio of 0.86 and a debt-to-equity ratio of 0.63. The company has a market capitalization of $40.32 billion, a P/E ratio of 38.21, a price-to-earnings-growth ratio of 3.27 and a beta of 0.83. The company's fifty day moving average is $22.61 and its 200-day moving average is $22.32.

Kenvue (NYSE:KVUE - Get Free Report) last issued its quarterly earnings results on Thursday, May 8th. The company reported $0.24 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.23 by $0.01. Kenvue had a return on equity of 20.87% and a net margin of 6.90%. The business had revenue of $3.74 billion during the quarter, compared to analyst estimates of $3.69 billion. During the same quarter in the prior year, the business posted $0.28 EPS. Kenvue's revenue for the quarter was down 3.9% compared to the same quarter last year. On average, research analysts expect that Kenvue Inc. will post 1.14 earnings per share for the current fiscal year.

Kenvue Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, May 28th. Shareholders of record on Wednesday, May 14th were issued a dividend of $0.205 per share. This represents a $0.82 annualized dividend and a dividend yield of 3.90%. The ex-dividend date was Wednesday, May 14th. Kenvue's dividend payout ratio (DPR) is presently 149.09%.

About Kenvue

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.